← Open Payments lookup

CHELSEA SIMPSON: Open Payments

NPI 1588366082 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,201 in 50 payments from 24 companies in 2025. Trend: 2023 $1,143 · 2024 $2,674 · 2025 $1,201

Food & beverage: $1,201
CompanyPaymentsAmount
Genmab U.S., Inc.5$111
PFIZER INC.5$102
AstraZeneca Pharmaceuticals LP4$99
Daiichi Sankyo Inc.3$79
Takeda Pharmaceuticals U.S.A., Inc.3$79
Merck Sharp & Dohme LLC3$78
Adaptive Biotechnologies Corporation3$71
Janssen Biotech, Inc.2$62
ABBVIE INC.2$59
Pharmacosmos Therapeutics Inc.2$57

Products named: KEYTRUDA, clonoSEQ, Tivdak, VENCLEXTA, MONOFERRIC, Enhertu, Lenvima, ELREXFIO.

Industry payments across IN — which companies pay providers there.